Experiment 636879

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationWAGNER,J: WAGNER,ML: HENING,WA:. (1998). BEYOND BENZODIAZEPINES: ALTERNATIVE PHARMACOLOGIC AGENTS FOR THE TREATMENT OF INSOMNIA.. 32(6)
Amount utilized
Compound isolated
DiseaseIN 300 SUBJECTS USING MELATONIN FOR AS LONG AS 1 MONTH, THE ONLY ADVERSE REACTIONS WERE ABDOMINAL CRAMPS WHEN AS MUCH AS 3-6 G WERE TAKEN. SINCE MELATONIN IS RAPIDLY ABSORBED AND HAS A SHORT HALF-LIFE OF 2-50 MINUTES, PATIENTS USUALLY DO NOT EXPERIENCE HANGOVER EFFECTS. SOME SUBJECTS INGESTING PHARMACOLOGIC DOSES OF MELATONIN HAVE EXPERIENCED FATIGUE, HEADACHE, DIZZINESS, AND INCREASED IRRITABILITY. THE EXACT INCIDENCE OF ADVERSE EFFECTS IS UNKNOWN BECAUSE THESE DATA ARE LACKING IN CLINICAL TRIALS AND MANUFACTURERS ARE NOT REQUIRED TO REPORT ADVERSE REACTIONS.
Dose amountVAR MG
Number12
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE